GeneFerm Biotechnology Co Ltd (1796) — Free Cash Flow Generation Index
GeneFerm Biotechnology Co Ltd (1796) has a Free Cash Flow Generation Index of -3.13x as of June 2025. Free cash flow of NT$-4.53 Million represents -3% of operating cash flow (NT$1.45 Million). Explore how much does GeneFerm Biotechnology Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GeneFerm Biotechnology Co Ltd Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for GeneFerm Biotechnology Co Ltd across 8 annual periods. For the full cash flow conversion analysis, see GeneFerm Biotechnology Co Ltd operating cash flow efficiency.
Annual Free Cash Flow Generation for GeneFerm Biotechnology Co Ltd (2017–2024)
Year-by-year Free Cash Flow Generation Index for GeneFerm Biotechnology Co Ltd. Check total reinvestment intensity of GeneFerm Biotechnology Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.81x | NT$-14.61 Million | NT$8.09 Million | NT$22.70 Million | ▼ -389.0% |
| 2023 | 0.62x | NT$118.91 Million | NT$190.31 Million | NT$71.40 Million | ▲ +149.0% |
| 2022 | -1.27x | NT$-155.98 Million | NT$122.43 Million | NT$278.42 Million | ▼ -328.4% |
| 2021 | -0.30x | NT$-33.37 Million | NT$112.23 Million | NT$145.61 Million | ▲ +35.2% |
| 2020 | -0.46x | NT$-25.90 Million | NT$56.42 Million | NT$82.32 Million | ▲ +83.1% |
| 2019 | -2.72x | NT$-39.89 Million | NT$14.69 Million | NT$54.57 Million | ▼ -995.1% |
| 2018 | 0.30x | NT$12.78 Million | NT$42.14 Million | NT$28.81 Million | ▲ +269.2% |
| 2017 | 0.08x | NT$5.02 Million | NT$61.08 Million | NT$55.16 Million | — |